| Symbol |
Name |
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
ANK2
|
ankyrin 2, neuronal
|
|
ANKRD1
|
ankyrin repeat domain 1 (cardiac muscle)
|
|
ANXA5
|
annexin A5
|
|
APLN
|
apelin
|
|
APLNR
|
apelin receptor
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BCL2L1
|
BCL2-like 1
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRCA1
|
breast cancer 1, early onset
|
|
C10ORF2
|
chromosome 10 open reading frame 2
|
|
C3
|
complement component 3
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CAMK2D
|
calcium/calmodulin-dependent protein kinase II delta
|
|
CAMTA1
|
calmodulin binding transcription activator 1
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASQ2
|
calsequestrin 2 (cardiac muscle)
|
|
CAV3
|
caveolin 3
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CHGA
|
chromogranin A
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
DFFA
|
DNA fragmentation factor, 45kDa, alpha polypeptide
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DMD
|
dystrophin
|
|
DOCK1
|
dedicator of cytokinesis 1
|
|
EDN1
|
endothelin 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
ESR1
|
estrogen receptor 1
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FKBP1A
|
FK506 binding protein 1A, 12kDa
|
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar)
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HSF1
|
heat shock transcription factor 1
|
|
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IL15
|
interleukin 15
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
INHBA
|
inhibin, beta A
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ISL1
|
ISL LIM homeobox 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KCNJ12
|
potassium channel, inwardly rectifying subfamily J, member 12
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ4
|
potassium channel, inwardly rectifying subfamily J, member 4
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
LCN2
|
lipocalin 2
|
|
LMNA
|
lamin A/C
|
|
MAFD2
|
major affective disorder 2
|
|
MEIS1
|
Meis homeobox 1
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR130A
|
microRNA 130a
|
|
MIR143
|
microRNA 143
|
|
MIR17HG
|
miR-17-92 cluster host gene
|
|
MIR195
|
microRNA 195
|
|
MIR204
|
microRNA 204
|
|
MIR21
|
microRNA 21
|
|
MIR34A
|
microRNA 34a
|
|
MIR499A
|
microRNA 499a
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYOCD
|
myocardin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NOL3
|
nucleolar protein 3 (apoptosis repressor with CARD domain)
|
|
NOS1AP
|
nitric oxide synthase 1 (neuronal) adaptor protein
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOX4
|
NADPH oxidase 4
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PCMT1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase
|
|
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated
|
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PLA2G5
|
phospholipase A2, group V
|
|
PLCB4
|
phospholipase C, beta 4
|
|
PLN
|
phospholamban
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKCD
|
protein kinase C, delta
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
RANGRF
|
RAN guanine nucleotide release factor
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REN
|
renin
|
|
RETN
|
resistin
|
|
RHEBP1
|
Ras-homolog enriched in brain pseudogene 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A6
|
S100 calcium binding protein A6
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SELK
|
selenoprotein K
|
|
SIRT3
|
sirtuin 3
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SORBS2
|
sorbin and SH3 domain containing 2
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STC1
|
stanniocalcin 1
|
|
STK4
|
serine/threonine kinase 4
|
|
TAZ
|
tafazzin
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THAP5
|
THAP domain containing 5
|
|
TLX2
|
T-cell leukemia homeobox 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNNI3K
|
TNNI3 interacting kinase
|
|
TP53
|
tumor protein p53
|
|
UBC
|
ubiquitin C
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
XBP1
|
X-box binding protein 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
YBX1
|
Y box binding protein 1
|
